If you or someone close to you has Type 2 diabetes, you know how difficult it can be to manage blood-sugar levels. It’s a never-ending balancing act that often requires two daily needles of the drug exenatide. But there’s new hope in diabetes management, thanks to researchers at the University of Toronto. Its study of 259 patients, published today in the British medical journal The Lancet, showed that twice-daily shots to control blood-sugar levels may become a thing of the past, and that just one shot a week of a long-acting form of exenatide might be enough. There are potential side effects for both the weekly and twice-daily users, such as nausea, but the incidence was lower in the patients getting weekly treatments, according to the study.
Do you know someone who will benefit from this good news?
Don’t miss a single Best Health Blog post—subscribe today via RSS or email!